Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients

Francesca Romito, Francesco Giuliani, Claudia Cormio, Cinzia Tulipani, Vittorio Mattioli, Giuseppe Colucci

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Goals of work: Advanced colorectal cancer (CRC) has recently been treated with monoclonal antibodies, such as cetuximab. Skin toxicity is a peculiar side effect of cetuximab that may induce patients to interrupt therapy if it becomes serious. This study investigates the psychological and social sequelae of skin rash. Materials and methods: Patients affected by advanced CRC and treated with cetuximab-based therapy entered the trial. The following questionnaires were used: the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) to measure quality of life (QoL) and the Psychological Distress Inventory (PDI). A single item regarding social avoidance was added with a three-point Likert scale. Toxicity was assessed using the National Cancer Institute Criteria (NCI-2). Main results: Eighty patients were recruited; 41% presented psychological distress. As regards social avoidance, 53% of patients answered that they did not avoid going out at all. The rest of the sample answered that they "very much" (22%) or "somewhat" (25%) avoided going out. Psychological distress and social avoidance were not correlated to skin rash, but only to QoL. Conclusion: Skin rash was not found to impact patients' psychological status or social life. Two likely explanations for this finding were that (a) patients with advanced cancer consider skin rash as a part of the complex suffering caused by cancer and (b) patients are encouraged by oncologists to continue treatment because skin rash is indicative of response to therapy. This expectation brings hope and helps patients bear the drug-related side effects.

Original languageEnglish
Pages (from-to)329-334
Number of pages6
JournalSupportive Care in Cancer
Volume18
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Exanthema
Colorectal Neoplasms
Psychology
Hope
Quality of Life
Therapeutics
National Cancer Institute (U.S.)
Cetuximab
Skin Neoplasms
Drug-Related Side Effects and Adverse Reactions
Psychological Stress
Monoclonal Antibodies
Equipment and Supplies
Skin
Neoplasms

Keywords

  • Advanced colorectal cancer
  • Cetuximab
  • Psychological distress
  • Quality of life
  • Skin rash

ASJC Scopus subject areas

  • Oncology

Cite this

Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients. / Romito, Francesca; Giuliani, Francesco; Cormio, Claudia; Tulipani, Cinzia; Mattioli, Vittorio; Colucci, Giuseppe.

In: Supportive Care in Cancer, Vol. 18, No. 3, 03.2010, p. 329-334.

Research output: Contribution to journalArticle

Romito, Francesca ; Giuliani, Francesco ; Cormio, Claudia ; Tulipani, Cinzia ; Mattioli, Vittorio ; Colucci, Giuseppe. / Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients. In: Supportive Care in Cancer. 2010 ; Vol. 18, No. 3. pp. 329-334.
@article{8ff611e39d8f404e9b665206a441f7c6,
title = "Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients",
abstract = "Goals of work: Advanced colorectal cancer (CRC) has recently been treated with monoclonal antibodies, such as cetuximab. Skin toxicity is a peculiar side effect of cetuximab that may induce patients to interrupt therapy if it becomes serious. This study investigates the psychological and social sequelae of skin rash. Materials and methods: Patients affected by advanced CRC and treated with cetuximab-based therapy entered the trial. The following questionnaires were used: the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) to measure quality of life (QoL) and the Psychological Distress Inventory (PDI). A single item regarding social avoidance was added with a three-point Likert scale. Toxicity was assessed using the National Cancer Institute Criteria (NCI-2). Main results: Eighty patients were recruited; 41{\%} presented psychological distress. As regards social avoidance, 53{\%} of patients answered that they did not avoid going out at all. The rest of the sample answered that they {"}very much{"} (22{\%}) or {"}somewhat{"} (25{\%}) avoided going out. Psychological distress and social avoidance were not correlated to skin rash, but only to QoL. Conclusion: Skin rash was not found to impact patients' psychological status or social life. Two likely explanations for this finding were that (a) patients with advanced cancer consider skin rash as a part of the complex suffering caused by cancer and (b) patients are encouraged by oncologists to continue treatment because skin rash is indicative of response to therapy. This expectation brings hope and helps patients bear the drug-related side effects.",
keywords = "Advanced colorectal cancer, Cetuximab, Psychological distress, Quality of life, Skin rash",
author = "Francesca Romito and Francesco Giuliani and Claudia Cormio and Cinzia Tulipani and Vittorio Mattioli and Giuseppe Colucci",
year = "2010",
month = "3",
doi = "10.1007/s00520-009-0656-9",
language = "English",
volume = "18",
pages = "329--334",
journal = "Supportive Care in Cancer",
issn = "0941-4355",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Psychological effects of cetuximab-induced cutaneous rash in advanced colorectal cancer patients

AU - Romito, Francesca

AU - Giuliani, Francesco

AU - Cormio, Claudia

AU - Tulipani, Cinzia

AU - Mattioli, Vittorio

AU - Colucci, Giuseppe

PY - 2010/3

Y1 - 2010/3

N2 - Goals of work: Advanced colorectal cancer (CRC) has recently been treated with monoclonal antibodies, such as cetuximab. Skin toxicity is a peculiar side effect of cetuximab that may induce patients to interrupt therapy if it becomes serious. This study investigates the psychological and social sequelae of skin rash. Materials and methods: Patients affected by advanced CRC and treated with cetuximab-based therapy entered the trial. The following questionnaires were used: the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) to measure quality of life (QoL) and the Psychological Distress Inventory (PDI). A single item regarding social avoidance was added with a three-point Likert scale. Toxicity was assessed using the National Cancer Institute Criteria (NCI-2). Main results: Eighty patients were recruited; 41% presented psychological distress. As regards social avoidance, 53% of patients answered that they did not avoid going out at all. The rest of the sample answered that they "very much" (22%) or "somewhat" (25%) avoided going out. Psychological distress and social avoidance were not correlated to skin rash, but only to QoL. Conclusion: Skin rash was not found to impact patients' psychological status or social life. Two likely explanations for this finding were that (a) patients with advanced cancer consider skin rash as a part of the complex suffering caused by cancer and (b) patients are encouraged by oncologists to continue treatment because skin rash is indicative of response to therapy. This expectation brings hope and helps patients bear the drug-related side effects.

AB - Goals of work: Advanced colorectal cancer (CRC) has recently been treated with monoclonal antibodies, such as cetuximab. Skin toxicity is a peculiar side effect of cetuximab that may induce patients to interrupt therapy if it becomes serious. This study investigates the psychological and social sequelae of skin rash. Materials and methods: Patients affected by advanced CRC and treated with cetuximab-based therapy entered the trial. The following questionnaires were used: the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) to measure quality of life (QoL) and the Psychological Distress Inventory (PDI). A single item regarding social avoidance was added with a three-point Likert scale. Toxicity was assessed using the National Cancer Institute Criteria (NCI-2). Main results: Eighty patients were recruited; 41% presented psychological distress. As regards social avoidance, 53% of patients answered that they did not avoid going out at all. The rest of the sample answered that they "very much" (22%) or "somewhat" (25%) avoided going out. Psychological distress and social avoidance were not correlated to skin rash, but only to QoL. Conclusion: Skin rash was not found to impact patients' psychological status or social life. Two likely explanations for this finding were that (a) patients with advanced cancer consider skin rash as a part of the complex suffering caused by cancer and (b) patients are encouraged by oncologists to continue treatment because skin rash is indicative of response to therapy. This expectation brings hope and helps patients bear the drug-related side effects.

KW - Advanced colorectal cancer

KW - Cetuximab

KW - Psychological distress

KW - Quality of life

KW - Skin rash

UR - http://www.scopus.com/inward/record.url?scp=77949270340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949270340&partnerID=8YFLogxK

U2 - 10.1007/s00520-009-0656-9

DO - 10.1007/s00520-009-0656-9

M3 - Article

C2 - 19484487

AN - SCOPUS:77949270340

VL - 18

SP - 329

EP - 334

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

SN - 0941-4355

IS - 3

ER -